Axiom Investors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$125M Buy
+491,072
New +$114M 1.08% 19
2013
Q4
– Sell
-12,100
Closed -$1.05M – 153
2013
Q3
$1.05M Sell
12,100
-350,928
-97% -$31.5M 0.03% 125
2013
Q2
$31.2M Buy
+363,028
New +$30.8M 1.13% 44

Other funds holding JNJ

Axiom Investors's JNJ Position: Q2 2026 in Review

Axiom Investors opened a new position in Johnson & Johnson (JNJ) in Q2 2026: 491,072 shares worth $125M. The stake represents 1.08% of the portfolio and ranks #19 among its holdings. This is a return to the name: Axiom Investors previously reported a position in JNJ as recently as Q3 2013.

Axiom Investors first reported a position in JNJ in Q2 2013 and has held it in 3 quarters since. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Axiom Investors held 491,072 shares of Johnson & Johnson worth $125M as of Q2 2026.
  • Johnson & Johnson was a new Axiom Investors position in Q2 2026.
  • Johnson & Johnson made up 1.08% of Axiom Investors's portfolio in Q2 2026, its #19 holding.
  • Axiom Investors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 3 quarters since.
  • 4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Axiom Investors's 13F filing for Q2 2026, filed 12 Aug 2026.